Drug Trial Radar · NCT07260669
A Phase 2 Trial to Investigate Efficacy and Safety of Vipoglanstat in Women With Endometriosis
Last checked: Nov 19, 2026Latest source record: Oct 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
213
Actual
Start
Oct 15, 2025
Primary completion
Jun 2027
Study completion Jun 2027
Sponsor
- Lead sponsor
- Gesynta Pharma ABIndustry
- Sponsor type
- Industry
- First posted
- Dec 3, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Female only, from 18 years, up to 44 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main objective of the trial is to evaluate the efficacy of vipoglanstat on endometriosis-related non-menstrual pelvic pain (NMPP).
Conditions
- Endometriosis
Interventions
VipoglanstatDrug
Participants will receive vipoglanstat capsules orally for approximately 4 menstrual cycles during the treatment period.
PlaceboDrug
Participants will receive matching placebo capsules orally for approximately 4 menstrual cycles during the treatment period.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants who meet the Predefined NMPP Responder Criteria from Baseline to Fourth Month of TreatmentTime frame: Baseline to 4 months
Locations
44 sites in 7 countries. Site status is shown where the registry gives one.
MHAT Puls AD
Blagoevgrad, Bulgaria
Lyulin Hospital
Sofia, Bulgaria
FemiClinic
Sofia, Bulgaria
Gynekologie MEDA s.r.o
Brno, Czechia
Fakultni nemocnice Brno
Brno, Czechia
NEUMED Gynekologicka Ambulance s.r.o.
Olomouc, Czechia
Gyncare MUDr. Michael Svec s.r.o.
Pilsen, Czechia
Fakultni nemocnice Kralovske Vinohrady
Prague, Czechia
STELLA-GYN, s.r.o.
Vodňany, Czechia
MedEnd
Budapest, Hungary
Semmelweis Egyetem II. Sz. Szuleszeti es Nogyogyaszati Klinika
Budapest, Hungary
Robert Karoly Private Hospital Tritonlife Medical Center
Budapest, Hungary
Debreceni Egyetem Klinikai Kozpont
Debrecen, Hungary
Somogy Varmegyei Kaposi Mor Oktato Korhaz (Kaposi Mor County Hospital)
Kaposvár, Hungary
A.O. San Martino Genova Universita di Genova
Genova, Italy
Prywatna Klinika Polozniczo - Ginekologiczna Sp. Z O.O.
Bialystok, Poland
Centrum Ginekologii Artemida
Bialystok, Poland
In- Vivo Sp. z o. o.
Bydgoszcz, Poland
NZOZ Medem
Katowice, Poland
Centrum Medyczne Angelius Provita
Katowice, Poland
NZOZ Vita Longa Sp. z o.o.
Katowice, Poland
Medico Praktyka Lekarska
Krakow, Poland
Centrum Medyczne Chodzki
Lublin, Poland
ETG Siedlce
Siedlce, Poland
Aidport sp. Z o.o.
Skorzewo, Poland
Twoja Przychodnia SCM
Szczecin, Poland
Specjalistyczna Praktyka Lekarska Krzysztof Dynowski
Warsaw, Poland
ETG JustMed
Warsaw, Poland
Genesys Fertility Center
Bucharest, Romania
Delta Health Care
Bucharest, Romania
Spitalul Clinic Filantropia
Bucharest, Romania
SC Centrul Medical Unirea SRL - Regina Maria
Iași, Romania
Spitalul Clinic Judetean de Urgenta Targu-Mures
Târgu Mureş, Romania
SC Centrul Medical Unirea SRL
Târgu Mureş, Romania
Accellacare Yorkshire
Bradford, United Kingdom
Southmead Hospital - North Bristol NHS Trust
Bristol, United Kingdom
Accellacare Northamptonshire
Corby, United Kingdom
Accellacare Warwickshire
Coventry, United Kingdom
Guy's and St Thomas' NHS Foundation Trust
London, United Kingdom
Accellacare North London
Northwood, United Kingdom
Showing 40 of 44 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.